Literature DB >> 6519168

Presence of chlorprothixene and its metabolites in breast milk.

I Matheson, A Evang, K F Overø, G Syversen.   

Abstract

Chlorprothixene (CPX) and CPX sulphoxide were demonstrated in breast milk from two psychotic mothers taking 200 mg CPX daily. The milk concentrations of CPX were 120 to 260% greater than in plasma. The estimated amounts of drug administered in breast milk to one of the infants were 15 and 26 micrograms/day for CPX and CPX sulphoxide, respectively. Accordingly, the infant dose of the parent compound would be only 0.1% of the maternal dose/kg body weight. It is not likely that CPX or its metabolite would exert any immediate pharmacological effects in the nursing infant. However, the long term effect of low doses of neuroleptic drugs in the developing infants is not yet known.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6519168     DOI: 10.1007/bf00556901

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  On the pharmacokinetics of chlorprothixene in man.

Authors:  J Raaflaub
Journal:  Experientia       Date:  1975-05-15

2.  Chlorprothixene and its metabolites in blood, liver and urine from fatal poisoning.

Authors:  H Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-01

3.  Learning deficits in 4 weeks old offspring of the nursing mothers treated with the neuroleptic drug penfluridol.

Authors:  S Ahlenius; R Brown; J Engel; P Lundborg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Abnormal ontogeny in young rabbits after chronic administration of haloperidol to the nursing mothers.

Authors:  P Lundborg
Journal:  Brain Res       Date:  1972-09-29       Impact factor: 3.252

5.  Appearance of chlorpromazine in the mother's milk.

Authors:  F Uhlír; J Rýznar
Journal:  Act Nerv Super (Praha)       Date:  1973-05

6.  Chlorpromazine levels in plasma and milk of nursing mothers.

Authors:  D H Wiles; M W Orr; T Kolakowska
Journal:  Br J Clin Pharmacol       Date:  1978-03       Impact factor: 4.335

7.  Infant growth and human milk requirements. A fresh approach.

Authors:  R G Whitehead; A A Paul
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

Review 8.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

9.  Anticholinergic and cardiodepressive effects of levomepromazine and two of its metabolites on isolated rat atria.

Authors:  M Passwal; S G Dahl; H Refsum
Journal:  Eur J Pharmacol       Date:  1976-12       Impact factor: 4.432

10.  Concentrations of Cis(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum, and milk.

Authors:  L Kirk; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  10 in total
  6 in total

Review 1.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

Review 2.  A guide to the safety of CNS-active agents during breastfeeding.

Authors:  C A Chisholm; J A Kuller
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 3.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 4.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

Review 5.  Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations.

Authors:  G Pons; E Rey; I Matheson
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

6.  Zuclopenthixol levels in serum and breast milk.

Authors:  T Aaes-Jørgensen; F Bjørndal; U Bartels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.